(35) found that the administration of GEM induced ROS generation in HCC and activated Ets2 to upregulate CD13 expression, and the activated expression of CD13 induced GEM resistance by activating NRF1 to upregulate GPX3 expression to clear intracellular ROS levels in HCC. The gene discussed is ETS2; the disease is hepatocellular carcinoma.